Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy
Regenerative Biomaterials · 17.01.2023 · 10
DOI: 10.1093/rb/rbad004 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Regenerative Biomaterials, online erschienen am 20.01.2023. Verfasst von Qiaolin Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Henan Institutes of Advanced Technology, Zhengzhou University, Zhengzhou 450052, China. Die Arbeit wurde bisher 90-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Program for International S&T Cooperation Projects, National Natural Science Foundation of China, National Key R&D Program of China.
Abstract (Originalsprache)
Ferroptosis, a completely new form of regulated cell death, is mainly caused by an imbalance between oxidative damage and reductive protection and has shown great anti-cancer potential. However, existing small-molecule ferroptosis inducers have various limitations, such as poor water solubility, drug resistance and low targeting ability, hindering their clinical applications. Nanotechnology provides new opportunities for ferroptosis-driven tumor therapy. Especially, stimuli-responsive nanomaterials stand out among others and have been widely researched because of their unique spatiotemporal control advantages. Therefore, it’s necessary to summarize the application of those stimuli-responsive nanomaterials in ferroptosis. Here, we describe the physiological feature of ferroptosis and illustrate the current challenges to induce ferroptosis for cancer therapy. Then, nanomaterials that induce ferroptosis are classified and elaborated according to the external and internal stimuli. Finally, the future perspectives in the field are proposed. We hope this review facilitates paving the way for the design of intelligent nano-ferroptosis inducers.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Henan Institutes of Advanced Technology, Zhengzhou University, Zhengzhou 450052, China.
- CAS Key Laboratory for Biomedical Effects of Nanoparticles and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology, Beijing 100190, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Research Unit of Nanoscience and Technology, Chinese Academy of Medical Sciences, Beijing 100039, China.
- The GBA National Institute for Nanotechnology Innovation, Guangzhou 510700, Guangdong, China.
ORCID-Profile: Chunying Chen
Förderung
- Program for International S&T Cooperation Projects
- National Natural Science Foundation of China
- National Key R&D Program of China
- Strategic Priority Research Program of the Chinese Academy of Sciences
- CAS Key Research Program for Frontier Sciences
- CAMS Innovation Fund for Medical Sciences
- Research and Development Project in Key Areas of Guangdong Province
Zitieren
APA
Liu, Q., Zhao, Y., Zhou, H., & Chen, C. (2023). Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy. Regenerative Biomaterials, 10. https://doi.org/10.1093/rb/rbad004
Vancouver
Liu Q, Zhao Y, Zhou H, Chen C. Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy. Regenerative Biomaterials. 2023;10. doi:10.1093/rb/rbad004
BibTeX
@article{Liu2023,
author = {Liu, Qiaolin and Zhao, Yuliang and Zhou, Huige and Chen, Chunying},
title = {Ferroptosis: challenges and opportunities for nanomaterials in cancer therapy},
journal = {Regenerative Biomaterials},
year = {2023},
volume = {10},
doi = {10.1093/rb/rbad004}
}
EUVIMED